Immudex is a life science company and trusted partner of scientists spearheading the global adoption of precision immune monitoring. Immudex’s Dextramer® technology enables superior detection of antigen-specific immune cells.
Immudex’s product portfolio allows scientists to investigate diverse types of immune cells, including T cells, non-conventional T cells, B cells and CAR cells using flow cytometry, next generation sequencing and single-cell multi-omics.
Company Details
- Employees
- 56
- Founded
- -
- Address
- Bredevej 2a, Copenhagen,capital Region 2830,denmark
- Phone
- +45 31 10 91 91
- in****@****dex.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- immudex.com
- Keywords
- Flow cytometry, Single-cell Multi-omics, Immune Monitoring, CAR cell detection and characterization, Antigen-specific T and B cells, Non-conventional T cells, MHC multimers, Dextramer® Technology, CAR Dextramer®, T cell stimulation, GMP reagents, Klickmer® Technology, TCR discovery, U-Load Dextramer®, dCODE Dextramer®, MHC Monomers, MAIT cells, iNKT cells, TCR Dextramer®, Soluble TCR Monomers, Custom Solutions & Services, pMHC Binding Screening Service, Custom allele development.
- HQ
- Copenhagen, Capital Region
Immudex Questions
Immudex's helpline number is +45 31 10 91 91
Immudex's website is immudex.com
Immudex's LinkedIn profile is https://www.linkedin.com/company/immudex
Immudex has
56 employees.
View email and phone details for 56
employees at Immudex.
Immudex's industry is
Biotechnology Research
Immudex's top competitors are
Acesion Pharma,
Bioxpedia A/s,
Bionordika Denmark A/s,
Adcendo,
Evaxion A/s,
Symphogen,
Nordic Bioscience,
Hemab Therapeutics,
Genmab,
Io Biotech.
Immudex's support email address is info@immudex.com
Immudex's categories are Biotechnology Research
Immudex's founding year is 2009
